nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—SLC22A1—Estropipate—osteoporosis	0.147	0.195	CbGbCtD
Ranitidine—SLC22A8—Conjugated Estrogens—osteoporosis	0.0688	0.091	CbGbCtD
Ranitidine—SLC22A1—Estradiol—osteoporosis	0.0612	0.0809	CbGbCtD
Ranitidine—SLC22A8—Estradiol—osteoporosis	0.0604	0.0799	CbGbCtD
Ranitidine—CYP1A2—Estropipate—osteoporosis	0.0516	0.0683	CbGbCtD
Ranitidine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0291	0.0385	CbGbCtD
Ranitidine—CYP2C19—Cholecalciferol—osteoporosis	0.0288	0.0381	CbGbCtD
Ranitidine—CYP3A5—Estradiol—osteoporosis	0.0288	0.0381	CbGbCtD
Ranitidine—CYP3A4—Estropipate—osteoporosis	0.027	0.0358	CbGbCtD
Ranitidine—CYP3A4—Calcitriol—osteoporosis	0.027	0.0358	CbGbCtD
Ranitidine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0244	0.0323	CbGbCtD
Ranitidine—CYP2C19—Estradiol—osteoporosis	0.0232	0.0307	CbGbCtD
Ranitidine—CYP2D6—Cholecalciferol—osteoporosis	0.0219	0.029	CbGbCtD
Ranitidine—CYP3A4—Ergocalciferol—osteoporosis	0.0216	0.0286	CbGbCtD
Ranitidine—CYP1A2—Estradiol—osteoporosis	0.0214	0.0284	CbGbCtD
Ranitidine—ABCB1—Conjugated Estrogens—osteoporosis	0.0213	0.0282	CbGbCtD
Ranitidine—ABCB1—Estradiol—osteoporosis	0.0187	0.0248	CbGbCtD
Ranitidine—CYP3A4—Raloxifene—osteoporosis	0.018	0.0239	CbGbCtD
Ranitidine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0174	0.0231	CbGbCtD
Ranitidine—CYP3A4—Cholecalciferol—osteoporosis	0.0139	0.0184	CbGbCtD
Ranitidine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0128	0.0169	CbGbCtD
Ranitidine—CYP3A4—Estradiol—osteoporosis	0.0112	0.0149	CbGbCtD
Ranitidine—Anaemia—Pamidronate—osteoporosis	0.000399	0.00169	CcSEcCtD
Ranitidine—Insomnia—Calcitriol—osteoporosis	0.000398	0.00169	CcSEcCtD
Ranitidine—Photosensitivity reaction—Estradiol—osteoporosis	0.000398	0.00169	CcSEcCtD
Ranitidine—Agitation—Pamidronate—osteoporosis	0.000397	0.00168	CcSEcCtD
Ranitidine—Constipation—Alendronate—osteoporosis	0.000395	0.00167	CcSEcCtD
Ranitidine—Pain—Alendronate—osteoporosis	0.000395	0.00167	CcSEcCtD
Ranitidine—Weight decreased—Estradiol—osteoporosis	0.000395	0.00167	CcSEcCtD
Ranitidine—Angioedema—Pamidronate—osteoporosis	0.000395	0.00167	CcSEcCtD
Ranitidine—Erythema—Zoledronate—osteoporosis	0.000395	0.00167	CcSEcCtD
Ranitidine—Discomfort—Ethinyl Estradiol—osteoporosis	0.000392	0.00166	CcSEcCtD
Ranitidine—Somnolence—Calcitriol—osteoporosis	0.000392	0.00166	CcSEcCtD
Ranitidine—Pneumonia—Estradiol—osteoporosis	0.000391	0.00166	CcSEcCtD
Ranitidine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.00039	0.00165	CcSEcCtD
Ranitidine—Malaise—Pamidronate—osteoporosis	0.00039	0.00165	CcSEcCtD
Ranitidine—Pain—Raloxifene—osteoporosis	0.000389	0.00164	CcSEcCtD
Ranitidine—Arthralgia—Risedronate—osteoporosis	0.000387	0.00164	CcSEcCtD
Ranitidine—Chest pain—Risedronate—osteoporosis	0.000387	0.00164	CcSEcCtD
Ranitidine—Myalgia—Risedronate—osteoporosis	0.000387	0.00164	CcSEcCtD
Ranitidine—Leukopenia—Pamidronate—osteoporosis	0.000387	0.00164	CcSEcCtD
Ranitidine—Alopecia—Conjugated Estrogens—osteoporosis	0.000386	0.00163	CcSEcCtD
Ranitidine—Pain—Ibandronate—osteoporosis	0.000385	0.00163	CcSEcCtD
Ranitidine—Constipation—Ibandronate—osteoporosis	0.000385	0.00163	CcSEcCtD
Ranitidine—Pruritus—Etidronic acid—osteoporosis	0.000384	0.00162	CcSEcCtD
Ranitidine—Feeling abnormal—Alendronate—osteoporosis	0.000381	0.00161	CcSEcCtD
Ranitidine—Erythema—Conjugated Estrogens—osteoporosis	0.00038	0.00161	CcSEcCtD
Ranitidine—Jaundice—Estradiol—osteoporosis	0.000379	0.0016	CcSEcCtD
Ranitidine—Pain—Calcitriol—osteoporosis	0.000377	0.00159	CcSEcCtD
Ranitidine—Constipation—Calcitriol—osteoporosis	0.000377	0.00159	CcSEcCtD
Ranitidine—Urticaria—Estropipate—osteoporosis	0.000373	0.00158	CcSEcCtD
Ranitidine—Vision blurred—Zoledronate—osteoporosis	0.000372	0.00157	CcSEcCtD
Ranitidine—Diarrhoea—Etidronic acid—osteoporosis	0.000371	0.00157	CcSEcCtD
Ranitidine—Abdominal pain—Estropipate—osteoporosis	0.000371	0.00157	CcSEcCtD
Ranitidine—Body temperature increased—Estropipate—osteoporosis	0.000371	0.00157	CcSEcCtD
Ranitidine—Feeling abnormal—Ibandronate—osteoporosis	0.000371	0.00157	CcSEcCtD
Ranitidine—Myalgia—Pamidronate—osteoporosis	0.000368	0.00156	CcSEcCtD
Ranitidine—Arthralgia—Pamidronate—osteoporosis	0.000368	0.00156	CcSEcCtD
Ranitidine—Urticaria—Alendronate—osteoporosis	0.000367	0.00155	CcSEcCtD
Ranitidine—Ill-defined disorder—Zoledronate—osteoporosis	0.000366	0.00155	CcSEcCtD
Ranitidine—Abdominal pain—Alendronate—osteoporosis	0.000365	0.00155	CcSEcCtD
Ranitidine—Body temperature increased—Alendronate—osteoporosis	0.000365	0.00155	CcSEcCtD
Ranitidine—Anaemia—Zoledronate—osteoporosis	0.000365	0.00154	CcSEcCtD
Ranitidine—Discomfort—Pamidronate—osteoporosis	0.000363	0.00154	CcSEcCtD
Ranitidine—Agitation—Zoledronate—osteoporosis	0.000363	0.00153	CcSEcCtD
Ranitidine—Angioedema—Zoledronate—osteoporosis	0.000361	0.00153	CcSEcCtD
Ranitidine—Abdominal pain—Raloxifene—osteoporosis	0.000359	0.00152	CcSEcCtD
Ranitidine—Body temperature increased—Raloxifene—osteoporosis	0.000359	0.00152	CcSEcCtD
Ranitidine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000358	0.00151	CcSEcCtD
Ranitidine—Urticaria—Ibandronate—osteoporosis	0.000358	0.00151	CcSEcCtD
Ranitidine—Malaise—Zoledronate—osteoporosis	0.000356	0.00151	CcSEcCtD
Ranitidine—Abdominal pain—Ibandronate—osteoporosis	0.000356	0.0015	CcSEcCtD
Ranitidine—Body temperature increased—Ibandronate—osteoporosis	0.000356	0.0015	CcSEcCtD
Ranitidine—Confusional state—Pamidronate—osteoporosis	0.000356	0.0015	CcSEcCtD
Ranitidine—Vertigo—Zoledronate—osteoporosis	0.000355	0.0015	CcSEcCtD
Ranitidine—Leukopenia—Zoledronate—osteoporosis	0.000353	0.00149	CcSEcCtD
Ranitidine—Anaphylactic shock—Pamidronate—osteoporosis	0.000353	0.00149	CcSEcCtD
Ranitidine—Urticaria—Calcitriol—osteoporosis	0.00035	0.00148	CcSEcCtD
Ranitidine—Hepatitis—Estradiol—osteoporosis	0.000349	0.00148	CcSEcCtD
Ranitidine—Body temperature increased—Calcitriol—osteoporosis	0.000348	0.00147	CcSEcCtD
Ranitidine—Abdominal pain—Calcitriol—osteoporosis	0.000348	0.00147	CcSEcCtD
Ranitidine—Angioedema—Conjugated Estrogens—osteoporosis	0.000347	0.00147	CcSEcCtD
Ranitidine—Hypersensitivity—Estropipate—osteoporosis	0.000346	0.00146	CcSEcCtD
Ranitidine—Thrombocytopenia—Pamidronate—osteoporosis	0.000345	0.00146	CcSEcCtD
Ranitidine—Vomiting—Etidronic acid—osteoporosis	0.000345	0.00146	CcSEcCtD
Ranitidine—Tachycardia—Pamidronate—osteoporosis	0.000344	0.00146	CcSEcCtD
Ranitidine—Rash—Etidronic acid—osteoporosis	0.000342	0.00145	CcSEcCtD
Ranitidine—Dermatitis—Etidronic acid—osteoporosis	0.000342	0.00145	CcSEcCtD
Ranitidine—Vertigo—Conjugated Estrogens—osteoporosis	0.000341	0.00144	CcSEcCtD
Ranitidine—Hyperhidrosis—Pamidronate—osteoporosis	0.000341	0.00144	CcSEcCtD
Ranitidine—Hypersensitivity—Alendronate—osteoporosis	0.000341	0.00144	CcSEcCtD
Ranitidine—Headache—Etidronic acid—osteoporosis	0.00034	0.00144	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000338	0.00143	CcSEcCtD
Ranitidine—Arthralgia—Zoledronate—osteoporosis	0.000336	0.00142	CcSEcCtD
Ranitidine—Myalgia—Zoledronate—osteoporosis	0.000336	0.00142	CcSEcCtD
Ranitidine—Chest pain—Zoledronate—osteoporosis	0.000336	0.00142	CcSEcCtD
Ranitidine—Insomnia—Risedronate—osteoporosis	0.000335	0.00142	CcSEcCtD
Ranitidine—Pruritus—Estropipate—osteoporosis	0.000332	0.0014	CcSEcCtD
Ranitidine—Discomfort—Zoledronate—osteoporosis	0.000332	0.0014	CcSEcCtD
Ranitidine—Hypersensitivity—Ibandronate—osteoporosis	0.000332	0.0014	CcSEcCtD
Ranitidine—Dyspnoea—Risedronate—osteoporosis	0.000331	0.0014	CcSEcCtD
Ranitidine—Erythema multiforme—Estradiol—osteoporosis	0.00033	0.0014	CcSEcCtD
Ranitidine—Hypotension—Pamidronate—osteoporosis	0.000329	0.00139	CcSEcCtD
Ranitidine—Pruritus—Alendronate—osteoporosis	0.000327	0.00138	CcSEcCtD
Ranitidine—Constipation—Ethinyl Estradiol—osteoporosis	0.000325	0.00138	CcSEcCtD
Ranitidine—Confusional state—Zoledronate—osteoporosis	0.000325	0.00137	CcSEcCtD
Ranitidine—Hypersensitivity—Calcitriol—osteoporosis	0.000325	0.00137	CcSEcCtD
Ranitidine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000323	0.00137	CcSEcCtD
Ranitidine—Myalgia—Conjugated Estrogens—osteoporosis	0.000323	0.00137	CcSEcCtD
Ranitidine—Chest pain—Conjugated Estrogens—osteoporosis	0.000323	0.00137	CcSEcCtD
Ranitidine—Nausea—Etidronic acid—osteoporosis	0.000322	0.00136	CcSEcCtD
Ranitidine—Anaphylactic shock—Zoledronate—osteoporosis	0.000322	0.00136	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000321	0.00136	CcSEcCtD
Ranitidine—Diarrhoea—Estropipate—osteoporosis	0.000321	0.00136	CcSEcCtD
Ranitidine—Insomnia—Pamidronate—osteoporosis	0.000319	0.00135	CcSEcCtD
Ranitidine—Pruritus—Ibandronate—osteoporosis	0.000318	0.00135	CcSEcCtD
Ranitidine—Pain—Risedronate—osteoporosis	0.000317	0.00134	CcSEcCtD
Ranitidine—Constipation—Risedronate—osteoporosis	0.000317	0.00134	CcSEcCtD
Ranitidine—Diarrhoea—Alendronate—osteoporosis	0.000316	0.00134	CcSEcCtD
Ranitidine—Thrombocytopenia—Zoledronate—osteoporosis	0.000315	0.00133	CcSEcCtD
Ranitidine—Dyspnoea—Pamidronate—osteoporosis	0.000314	0.00133	CcSEcCtD
Ranitidine—Tachycardia—Zoledronate—osteoporosis	0.000314	0.00133	CcSEcCtD
Ranitidine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000313	0.00133	CcSEcCtD
Ranitidine—Somnolence—Pamidronate—osteoporosis	0.000313	0.00133	CcSEcCtD
Ranitidine—Pruritus—Calcitriol—osteoporosis	0.000312	0.00132	CcSEcCtD
Ranitidine—Hyperhidrosis—Zoledronate—osteoporosis	0.000311	0.00132	CcSEcCtD
Ranitidine—Diarrhoea—Raloxifene—osteoporosis	0.000311	0.00132	CcSEcCtD
Ranitidine—Dizziness—Estropipate—osteoporosis	0.00031	0.00131	CcSEcCtD
Ranitidine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00031	0.00131	CcSEcCtD
Ranitidine—Alopecia—Estradiol—osteoporosis	0.000309	0.00131	CcSEcCtD
Ranitidine—Diarrhoea—Ibandronate—osteoporosis	0.000308	0.0013	CcSEcCtD
Ranitidine—Dizziness—Alendronate—osteoporosis	0.000306	0.00129	CcSEcCtD
Ranitidine—Erythema—Estradiol—osteoporosis	0.000304	0.00129	CcSEcCtD
Ranitidine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000303	0.00128	CcSEcCtD
Ranitidine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000302	0.00128	CcSEcCtD
Ranitidine—Constipation—Pamidronate—osteoporosis	0.000302	0.00128	CcSEcCtD
Ranitidine—Pain—Pamidronate—osteoporosis	0.000302	0.00128	CcSEcCtD
Ranitidine—Diarrhoea—Calcitriol—osteoporosis	0.000301	0.00128	CcSEcCtD
Ranitidine—Hypotension—Zoledronate—osteoporosis	0.000301	0.00127	CcSEcCtD
Ranitidine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000301	0.00127	CcSEcCtD
Ranitidine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000301	0.00127	CcSEcCtD
Ranitidine—Dizziness—Raloxifene—osteoporosis	0.000301	0.00127	CcSEcCtD
Ranitidine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.0003	0.00127	CcSEcCtD
Ranitidine—Vomiting—Estropipate—osteoporosis	0.000298	0.00126	CcSEcCtD
Ranitidine—Dizziness—Ibandronate—osteoporosis	0.000298	0.00126	CcSEcCtD
Ranitidine—Rash—Estropipate—osteoporosis	0.000296	0.00125	CcSEcCtD
Ranitidine—Dermatitis—Estropipate—osteoporosis	0.000296	0.00125	CcSEcCtD
Ranitidine—Urticaria—Risedronate—osteoporosis	0.000295	0.00125	CcSEcCtD
Ranitidine—Headache—Estropipate—osteoporosis	0.000294	0.00124	CcSEcCtD
Ranitidine—Vomiting—Alendronate—osteoporosis	0.000294	0.00124	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000293	0.00124	CcSEcCtD
Ranitidine—Abdominal pain—Risedronate—osteoporosis	0.000293	0.00124	CcSEcCtD
Ranitidine—Body temperature increased—Risedronate—osteoporosis	0.000293	0.00124	CcSEcCtD
Ranitidine—Rash—Alendronate—osteoporosis	0.000291	0.00123	CcSEcCtD
Ranitidine—Insomnia—Zoledronate—osteoporosis	0.000291	0.00123	CcSEcCtD
Ranitidine—Dermatitis—Alendronate—osteoporosis	0.000291	0.00123	CcSEcCtD
Ranitidine—Feeling abnormal—Pamidronate—osteoporosis	0.000291	0.00123	CcSEcCtD
Ranitidine—Hypotension—Conjugated Estrogens—osteoporosis	0.00029	0.00123	CcSEcCtD
Ranitidine—Headache—Alendronate—osteoporosis	0.00029	0.00122	CcSEcCtD
Ranitidine—Vomiting—Raloxifene—osteoporosis	0.000289	0.00122	CcSEcCtD
Ranitidine—Dyspnoea—Zoledronate—osteoporosis	0.000287	0.00121	CcSEcCtD
Ranitidine—Rash—Raloxifene—osteoporosis	0.000287	0.00121	CcSEcCtD
Ranitidine—Dermatitis—Raloxifene—osteoporosis	0.000286	0.00121	CcSEcCtD
Ranitidine—Somnolence—Zoledronate—osteoporosis	0.000286	0.00121	CcSEcCtD
Ranitidine—Vomiting—Ibandronate—osteoporosis	0.000286	0.00121	CcSEcCtD
Ranitidine—Headache—Raloxifene—osteoporosis	0.000285	0.0012	CcSEcCtD
Ranitidine—Rash—Ibandronate—osteoporosis	0.000284	0.0012	CcSEcCtD
Ranitidine—Dermatitis—Ibandronate—osteoporosis	0.000284	0.0012	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000283	0.0012	CcSEcCtD
Ranitidine—Ill-defined disorder—Estradiol—osteoporosis	0.000282	0.00119	CcSEcCtD
Ranitidine—Headache—Ibandronate—osteoporosis	0.000282	0.00119	CcSEcCtD
Ranitidine—Insomnia—Conjugated Estrogens—osteoporosis	0.00028	0.00119	CcSEcCtD
Ranitidine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00028	0.00119	CcSEcCtD
Ranitidine—Vomiting—Calcitriol—osteoporosis	0.00028	0.00118	CcSEcCtD
Ranitidine—Agitation—Estradiol—osteoporosis	0.000279	0.00118	CcSEcCtD
Ranitidine—Nausea—Estropipate—osteoporosis	0.000279	0.00118	CcSEcCtD
Ranitidine—Body temperature increased—Pamidronate—osteoporosis	0.000279	0.00118	CcSEcCtD
Ranitidine—Abdominal pain—Pamidronate—osteoporosis	0.000279	0.00118	CcSEcCtD
Ranitidine—Angioedema—Estradiol—osteoporosis	0.000278	0.00118	CcSEcCtD
Ranitidine—Rash—Calcitriol—osteoporosis	0.000278	0.00118	CcSEcCtD
Ranitidine—Dermatitis—Calcitriol—osteoporosis	0.000278	0.00117	CcSEcCtD
Ranitidine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000276	0.00117	CcSEcCtD
Ranitidine—Headache—Calcitriol—osteoporosis	0.000276	0.00117	CcSEcCtD
Ranitidine—Somnolence—Conjugated Estrogens—osteoporosis	0.000276	0.00117	CcSEcCtD
Ranitidine—Pain—Zoledronate—osteoporosis	0.000275	0.00117	CcSEcCtD
Ranitidine—Constipation—Zoledronate—osteoporosis	0.000275	0.00117	CcSEcCtD
Ranitidine—Nausea—Alendronate—osteoporosis	0.000275	0.00116	CcSEcCtD
Ranitidine—Malaise—Estradiol—osteoporosis	0.000274	0.00116	CcSEcCtD
Ranitidine—Hypersensitivity—Risedronate—osteoporosis	0.000273	0.00116	CcSEcCtD
Ranitidine—Vertigo—Estradiol—osteoporosis	0.000273	0.00116	CcSEcCtD
Ranitidine—Nausea—Raloxifene—osteoporosis	0.00027	0.00114	CcSEcCtD
Ranitidine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000269	0.00114	CcSEcCtD
Ranitidine—Nausea—Ibandronate—osteoporosis	0.000267	0.00113	CcSEcCtD
Ranitidine—Feeling abnormal—Zoledronate—osteoporosis	0.000265	0.00112	CcSEcCtD
Ranitidine—Constipation—Conjugated Estrogens—osteoporosis	0.000265	0.00112	CcSEcCtD
Ranitidine—Pain—Conjugated Estrogens—osteoporosis	0.000265	0.00112	CcSEcCtD
Ranitidine—Pruritus—Risedronate—osteoporosis	0.000262	0.00111	CcSEcCtD
Ranitidine—Nausea—Calcitriol—osteoporosis	0.000262	0.00111	CcSEcCtD
Ranitidine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00026	0.0011	CcSEcCtD
Ranitidine—Hypersensitivity—Pamidronate—osteoporosis	0.00026	0.0011	CcSEcCtD
Ranitidine—Arthralgia—Estradiol—osteoporosis	0.000259	0.0011	CcSEcCtD
Ranitidine—Myalgia—Estradiol—osteoporosis	0.000259	0.0011	CcSEcCtD
Ranitidine—Chest pain—Estradiol—osteoporosis	0.000259	0.0011	CcSEcCtD
Ranitidine—Urticaria—Zoledronate—osteoporosis	0.000256	0.00108	CcSEcCtD
Ranitidine—Discomfort—Estradiol—osteoporosis	0.000256	0.00108	CcSEcCtD
Ranitidine—Abdominal pain—Zoledronate—osteoporosis	0.000255	0.00108	CcSEcCtD
Ranitidine—Body temperature increased—Zoledronate—osteoporosis	0.000255	0.00108	CcSEcCtD
Ranitidine—Diarrhoea—Risedronate—osteoporosis	0.000254	0.00107	CcSEcCtD
Ranitidine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000252	0.00106	CcSEcCtD
Ranitidine—Confusional state—Estradiol—osteoporosis	0.00025	0.00106	CcSEcCtD
Ranitidine—Pruritus—Pamidronate—osteoporosis	0.000249	0.00106	CcSEcCtD
Ranitidine—Anaphylactic shock—Estradiol—osteoporosis	0.000248	0.00105	CcSEcCtD
Ranitidine—Urticaria—Conjugated Estrogens—osteoporosis	0.000246	0.00104	CcSEcCtD
Ranitidine—Dizziness—Risedronate—osteoporosis	0.000245	0.00104	CcSEcCtD
Ranitidine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000245	0.00104	CcSEcCtD
Ranitidine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000245	0.00104	CcSEcCtD
Ranitidine—Tachycardia—Estradiol—osteoporosis	0.000242	0.00102	CcSEcCtD
Ranitidine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000242	0.00102	CcSEcCtD
Ranitidine—Diarrhoea—Pamidronate—osteoporosis	0.000241	0.00102	CcSEcCtD
Ranitidine—Hyperhidrosis—Estradiol—osteoporosis	0.00024	0.00101	CcSEcCtD
Ranitidine—Rash—Ethinyl Estradiol—osteoporosis	0.00024	0.00101	CcSEcCtD
Ranitidine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00024	0.00101	CcSEcCtD
Ranitidine—Headache—Ethinyl Estradiol—osteoporosis	0.000238	0.00101	CcSEcCtD
Ranitidine—Hypersensitivity—Zoledronate—osteoporosis	0.000237	0.001	CcSEcCtD
Ranitidine—Vomiting—Risedronate—osteoporosis	0.000236	0.000998	CcSEcCtD
Ranitidine—Rash—Risedronate—osteoporosis	0.000234	0.000989	CcSEcCtD
Ranitidine—Dermatitis—Risedronate—osteoporosis	0.000234	0.000988	CcSEcCtD
Ranitidine—Dizziness—Pamidronate—osteoporosis	0.000233	0.000986	CcSEcCtD
Ranitidine—Headache—Risedronate—osteoporosis	0.000232	0.000983	CcSEcCtD
Ranitidine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000228	0.000966	CcSEcCtD
Ranitidine—Pruritus—Zoledronate—osteoporosis	0.000228	0.000964	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000226	0.000957	CcSEcCtD
Ranitidine—Nausea—Ethinyl Estradiol—osteoporosis	0.000226	0.000956	CcSEcCtD
Ranitidine—Insomnia—Estradiol—osteoporosis	0.000224	0.00095	CcSEcCtD
Ranitidine—Vomiting—Pamidronate—osteoporosis	0.000224	0.000948	CcSEcCtD
Ranitidine—Rash—Pamidronate—osteoporosis	0.000222	0.00094	CcSEcCtD
Ranitidine—Dermatitis—Pamidronate—osteoporosis	0.000222	0.00094	CcSEcCtD
Ranitidine—Dyspnoea—Estradiol—osteoporosis	0.000221	0.000936	CcSEcCtD
Ranitidine—Headache—Pamidronate—osteoporosis	0.000221	0.000934	CcSEcCtD
Ranitidine—Somnolence—Estradiol—osteoporosis	0.000221	0.000933	CcSEcCtD
Ranitidine—Diarrhoea—Zoledronate—osteoporosis	0.00022	0.000932	CcSEcCtD
Ranitidine—Nausea—Risedronate—osteoporosis	0.00022	0.000932	CcSEcCtD
Ranitidine—Pruritus—Conjugated Estrogens—osteoporosis	0.000219	0.000928	CcSEcCtD
Ranitidine—Dizziness—Zoledronate—osteoporosis	0.000213	0.000901	CcSEcCtD
Ranitidine—Constipation—Estradiol—osteoporosis	0.000212	0.000898	CcSEcCtD
Ranitidine—Pain—Estradiol—osteoporosis	0.000212	0.000898	CcSEcCtD
Ranitidine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000212	0.000898	CcSEcCtD
Ranitidine—Nausea—Pamidronate—osteoporosis	0.000209	0.000886	CcSEcCtD
Ranitidine—Dizziness—Conjugated Estrogens—osteoporosis	0.000205	0.000867	CcSEcCtD
Ranitidine—Vomiting—Zoledronate—osteoporosis	0.000205	0.000866	CcSEcCtD
Ranitidine—Feeling abnormal—Estradiol—osteoporosis	0.000205	0.000865	CcSEcCtD
Ranitidine—Rash—Zoledronate—osteoporosis	0.000203	0.000859	CcSEcCtD
Ranitidine—Dermatitis—Zoledronate—osteoporosis	0.000203	0.000858	CcSEcCtD
Ranitidine—Headache—Zoledronate—osteoporosis	0.000202	0.000853	CcSEcCtD
Ranitidine—Vomiting—Conjugated Estrogens—osteoporosis	0.000197	0.000834	CcSEcCtD
Ranitidine—Urticaria—Estradiol—osteoporosis	0.000197	0.000834	CcSEcCtD
Ranitidine—Body temperature increased—Estradiol—osteoporosis	0.000196	0.00083	CcSEcCtD
Ranitidine—Abdominal pain—Estradiol—osteoporosis	0.000196	0.00083	CcSEcCtD
Ranitidine—Rash—Conjugated Estrogens—osteoporosis	0.000196	0.000827	CcSEcCtD
Ranitidine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000195	0.000826	CcSEcCtD
Ranitidine—Headache—Conjugated Estrogens—osteoporosis	0.000194	0.000822	CcSEcCtD
Ranitidine—Nausea—Zoledronate—osteoporosis	0.000191	0.000809	CcSEcCtD
Ranitidine—Nausea—Conjugated Estrogens—osteoporosis	0.000184	0.000779	CcSEcCtD
Ranitidine—Hypersensitivity—Estradiol—osteoporosis	0.000183	0.000774	CcSEcCtD
Ranitidine—Pruritus—Estradiol—osteoporosis	0.000176	0.000743	CcSEcCtD
Ranitidine—Diarrhoea—Estradiol—osteoporosis	0.00017	0.000718	CcSEcCtD
Ranitidine—Dizziness—Estradiol—osteoporosis	0.000164	0.000694	CcSEcCtD
Ranitidine—Vomiting—Estradiol—osteoporosis	0.000158	0.000668	CcSEcCtD
Ranitidine—Rash—Estradiol—osteoporosis	0.000156	0.000662	CcSEcCtD
Ranitidine—Dermatitis—Estradiol—osteoporosis	0.000156	0.000661	CcSEcCtD
Ranitidine—Headache—Estradiol—osteoporosis	0.000155	0.000658	CcSEcCtD
Ranitidine—Nausea—Estradiol—osteoporosis	0.000147	0.000624	CcSEcCtD
Ranitidine—SLC22A1—Metabolism—PKM—osteoporosis	1.66e-05	0.00214	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.66e-05	0.00213	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.65e-05	0.00213	CbGpPWpGaD
Ranitidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	1.63e-05	0.0021	CbGpPWpGaD
Ranitidine—SLC22A1—Neuronal System—ADCY5—osteoporosis	1.63e-05	0.0021	CbGpPWpGaD
Ranitidine—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	1.62e-05	0.00209	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.61e-05	0.00208	CbGpPWpGaD
Ranitidine—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	1.6e-05	0.00206	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—POMC—osteoporosis	1.58e-05	0.00204	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PGLS—osteoporosis	1.58e-05	0.00203	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GPD2—osteoporosis	1.58e-05	0.00203	CbGpPWpGaD
Ranitidine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.55e-05	0.002	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CALCA—osteoporosis	1.55e-05	0.002	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TLN1—osteoporosis	1.5e-05	0.00193	CbGpPWpGaD
Ranitidine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.48e-05	0.0019	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PNP—osteoporosis	1.44e-05	0.00186	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ATIC—osteoporosis	1.44e-05	0.00186	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL1B—osteoporosis	1.43e-05	0.00184	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	1.37e-05	0.00177	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	1.37e-05	0.00176	CbGpPWpGaD
Ranitidine—CYP3A5—Biological oxidations—POMC—osteoporosis	1.37e-05	0.00176	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.37e-05	0.00176	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	1.37e-05	0.00176	CbGpPWpGaD
Ranitidine—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	1.35e-05	0.00174	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.35e-05	0.00174	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PKM—osteoporosis	1.29e-05	0.00166	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—FDPS—osteoporosis	1.29e-05	0.00166	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—P4HB—osteoporosis	1.29e-05	0.00166	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.29e-05	0.00166	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.29e-05	0.00166	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	1.28e-05	0.00164	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	1.28e-05	0.00164	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.25e-05	0.00162	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTH—osteoporosis	1.25e-05	0.00162	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—RAP1A—osteoporosis	1.23e-05	0.00159	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—OXCT1—osteoporosis	1.23e-05	0.00158	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CA2—osteoporosis	1.23e-05	0.00158	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PGLS—osteoporosis	1.22e-05	0.00158	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GPD2—osteoporosis	1.22e-05	0.00158	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CNR2—osteoporosis	1.22e-05	0.00158	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—ADCY5—osteoporosis	1.21e-05	0.00156	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NFATC1—osteoporosis	1.2e-05	0.00155	CbGpPWpGaD
Ranitidine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.2e-05	0.00154	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—MGLL—osteoporosis	1.19e-05	0.00154	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—DKK1—osteoporosis	1.19e-05	0.00154	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—WNT1—osteoporosis	1.15e-05	0.00148	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ATIC—osteoporosis	1.12e-05	0.00144	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PNP—osteoporosis	1.12e-05	0.00144	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—FGA—osteoporosis	1.12e-05	0.00144	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—TGFB1—osteoporosis	1.11e-05	0.00143	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—ADCY5—osteoporosis	1.1e-05	0.00142	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.09e-05	0.00141	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.06e-05	0.00136	CbGpPWpGaD
Ranitidine—CYP2C19—Biological oxidations—POMC—osteoporosis	1.06e-05	0.00136	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.06e-05	0.00136	CbGpPWpGaD
Ranitidine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.04e-05	0.00135	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTHLH—osteoporosis	1.04e-05	0.00134	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—BMP2—osteoporosis	1.04e-05	0.00134	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—TNF—osteoporosis	1.04e-05	0.00134	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—FGB—osteoporosis	1.02e-05	0.00131	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—IDH2—osteoporosis	1.02e-05	0.00131	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1e-05	0.00129	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PKM—osteoporosis	9.98e-06	0.00129	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—FDPS—osteoporosis	9.98e-06	0.00129	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PSMA2—osteoporosis	9.82e-06	0.00127	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PSMA5—osteoporosis	9.82e-06	0.00127	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—FDPS—osteoporosis	9.74e-06	0.00126	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PKM—osteoporosis	9.74e-06	0.00126	CbGpPWpGaD
Ranitidine—CYP2D6—Biological oxidations—POMC—osteoporosis	9.73e-06	0.00125	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CYP27A1—osteoporosis	9.55e-06	0.00123	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CA2—osteoporosis	9.52e-06	0.00123	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—OXCT1—osteoporosis	9.52e-06	0.00123	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GPD2—osteoporosis	9.46e-06	0.00122	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PGLS—osteoporosis	9.46e-06	0.00122	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ACP5—osteoporosis	9.29e-06	0.0012	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—MGLL—osteoporosis	9.28e-06	0.0012	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PGLS—osteoporosis	9.24e-06	0.00119	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GPD2—osteoporosis	9.24e-06	0.00119	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PKM—osteoporosis	9.18e-06	0.00118	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—FDPS—osteoporosis	9.18e-06	0.00118	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CALCA—osteoporosis	9.15e-06	0.00118	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	9.14e-06	0.00118	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—POMC—osteoporosis	8.92e-06	0.00115	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.75e-06	0.00113	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GPD2—osteoporosis	8.7e-06	0.00112	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PGLS—osteoporosis	8.7e-06	0.00112	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ATIC—osteoporosis	8.66e-06	0.00112	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PNP—osteoporosis	8.66e-06	0.00112	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—TPI1—osteoporosis	8.63e-06	0.00111	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.53e-06	0.0011	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ATIC—osteoporosis	8.45e-06	0.00109	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PNP—osteoporosis	8.45e-06	0.00109	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—KL—osteoporosis	8.31e-06	0.00107	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—POMC—osteoporosis	8.25e-06	0.00106	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—P4HB—osteoporosis	8.12e-06	0.00105	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—POMC—osteoporosis	8.1e-06	0.00104	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GAPDH—osteoporosis	7.97e-06	0.00103	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ATIC—osteoporosis	7.96e-06	0.00103	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PNP—osteoporosis	7.96e-06	0.00103	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—IL6R—osteoporosis	7.91e-06	0.00102	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—IDH2—osteoporosis	7.89e-06	0.00102	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PKM—osteoporosis	7.78e-06	0.001	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—FDPS—osteoporosis	7.78e-06	0.001	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—RAP1A—osteoporosis	7.76e-06	0.001	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP27A1—osteoporosis	7.42e-06	0.000956	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PGLS—osteoporosis	7.37e-06	0.00095	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GPD2—osteoporosis	7.37e-06	0.00095	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—OXCT1—osteoporosis	7.36e-06	0.000948	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CA2—osteoporosis	7.36e-06	0.000948	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ACP5—osteoporosis	7.21e-06	0.00093	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CA2—osteoporosis	7.18e-06	0.000926	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—OXCT1—osteoporosis	7.18e-06	0.000926	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—MGLL—osteoporosis	7.17e-06	0.000924	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—MGLL—osteoporosis	7e-06	0.000902	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—OXCT1—osteoporosis	6.77e-06	0.000872	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CA2—osteoporosis	6.77e-06	0.000872	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.76e-06	0.000872	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PNP—osteoporosis	6.74e-06	0.000869	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ATIC—osteoporosis	6.74e-06	0.000869	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—TPI1—osteoporosis	6.71e-06	0.000864	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—MGLL—osteoporosis	6.6e-06	0.00085	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—ADCY5—osteoporosis	6.51e-06	0.000839	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—POMC—osteoporosis	6.36e-06	0.00082	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—P4HB—osteoporosis	6.31e-06	0.000813	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SPP1—osteoporosis	6.3e-06	0.000812	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ENO1—osteoporosis	6.27e-06	0.000809	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GAPDH—osteoporosis	6.19e-06	0.000798	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PSMA2—osteoporosis	6.18e-06	0.000797	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PSMA5—osteoporosis	6.18e-06	0.000797	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—IDH2—osteoporosis	6.1e-06	0.000786	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—RAP1A—osteoporosis	6.03e-06	0.000777	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PKM—osteoporosis	6e-06	0.000774	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—FDPS—osteoporosis	6e-06	0.000774	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—IDH2—osteoporosis	5.95e-06	0.000767	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—OXCT1—osteoporosis	5.73e-06	0.000739	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CA2—osteoporosis	5.73e-06	0.000739	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP27A1—osteoporosis	5.73e-06	0.000739	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IRS2—osteoporosis	5.69e-06	0.000734	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PGLS—osteoporosis	5.69e-06	0.000733	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GPD2—osteoporosis	5.69e-06	0.000733	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—IDH2—osteoporosis	5.61e-06	0.000723	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP27A1—osteoporosis	5.6e-06	0.000721	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—MGLL—osteoporosis	5.59e-06	0.00072	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ACP5—osteoporosis	5.58e-06	0.000719	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—LEP—osteoporosis	5.57e-06	0.000718	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.51e-06	0.00071	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	5.49e-06	0.000708	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	5.48e-06	0.000706	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ACP5—osteoporosis	5.44e-06	0.000702	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—ESR1—osteoporosis	5.32e-06	0.000686	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP27A1—osteoporosis	5.27e-06	0.00068	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.27e-06	0.000679	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PNP—osteoporosis	5.2e-06	0.000671	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ATIC—osteoporosis	5.2e-06	0.000671	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—TPI1—osteoporosis	5.19e-06	0.000668	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ACP5—osteoporosis	5.13e-06	0.000661	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.13e-06	0.000661	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	5.12e-06	0.000659	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—TPI1—osteoporosis	5.06e-06	0.000652	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CYP19A1—osteoporosis	5.02e-06	0.000646	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IRS1—osteoporosis	4.97e-06	0.000641	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—P4HB—osteoporosis	4.88e-06	0.000628	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ENO1—osteoporosis	4.87e-06	0.000628	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PSMA5—osteoporosis	4.8e-06	0.000619	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PSMA2—osteoporosis	4.8e-06	0.000619	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—POMC—osteoporosis	4.79e-06	0.000617	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GAPDH—osteoporosis	4.79e-06	0.000617	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—TPI1—osteoporosis	4.77e-06	0.000615	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—P4HB—osteoporosis	4.76e-06	0.000613	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—IDH2—osteoporosis	4.75e-06	0.000612	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GAPDH—osteoporosis	4.67e-06	0.000602	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL6R—osteoporosis	4.67e-06	0.000602	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—RAP1A—osteoporosis	4.66e-06	0.000601	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IGF1—osteoporosis	4.61e-06	0.000593	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—RAP1A—osteoporosis	4.55e-06	0.000586	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—P4HB—osteoporosis	4.48e-06	0.000578	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP27A1—osteoporosis	4.47e-06	0.000576	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CA2—osteoporosis	4.43e-06	0.00057	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—OXCT1—osteoporosis	4.43e-06	0.00057	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GAPDH—osteoporosis	4.4e-06	0.000567	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ACP5—osteoporosis	4.35e-06	0.00056	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—MGLL—osteoporosis	4.31e-06	0.000556	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.29e-06	0.000553	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—RAP1A—osteoporosis	4.29e-06	0.000552	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ADCY5—osteoporosis	4.1e-06	0.000528	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GPX1—osteoporosis	4.08e-06	0.000526	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.06e-06	0.000524	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—TPI1—osteoporosis	4.04e-06	0.000521	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP19A1—osteoporosis	3.9e-06	0.000502	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—P4HB—osteoporosis	3.8e-06	0.00049	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—MTHFR—osteoporosis	3.77e-06	0.000486	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ENO1—osteoporosis	3.77e-06	0.000486	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GAPDH—osteoporosis	3.73e-06	0.000481	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PSMA2—osteoporosis	3.71e-06	0.000478	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PSMA5—osteoporosis	3.71e-06	0.000478	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ENO1—osteoporosis	3.68e-06	0.000474	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—IDH2—osteoporosis	3.67e-06	0.000473	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—RAP1A—osteoporosis	3.63e-06	0.000468	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PSMA2—osteoporosis	3.62e-06	0.000467	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PSMA5—osteoporosis	3.62e-06	0.000467	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—IL6—osteoporosis	3.52e-06	0.000454	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ENO1—osteoporosis	3.47e-06	0.000447	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP27A1—osteoporosis	3.45e-06	0.000444	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PSMA2—osteoporosis	3.41e-06	0.00044	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PSMA5—osteoporosis	3.41e-06	0.00044	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ACP5—osteoporosis	3.35e-06	0.000432	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ADCY5—osteoporosis	3.18e-06	0.00041	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GPX1—osteoporosis	3.17e-06	0.000409	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.17e-06	0.000408	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—TPI1—osteoporosis	3.12e-06	0.000402	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—POMC—osteoporosis	3.01e-06	0.000388	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP19A1—osteoporosis	3.01e-06	0.000388	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP19A1—osteoporosis	2.94e-06	0.000379	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ENO1—osteoporosis	2.94e-06	0.000378	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—P4HB—osteoporosis	2.93e-06	0.000378	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—MTHFR—osteoporosis	2.93e-06	0.000377	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PSMA2—osteoporosis	2.89e-06	0.000373	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PSMA5—osteoporosis	2.89e-06	0.000373	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GAPDH—osteoporosis	2.88e-06	0.000371	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—RAP1A—osteoporosis	2.8e-06	0.000361	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP19A1—osteoporosis	2.77e-06	0.000357	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MYC—osteoporosis	2.77e-06	0.000357	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TGFB1—osteoporosis	2.76e-06	0.000356	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ADCY5—osteoporosis	2.46e-06	0.000317	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GPX1—osteoporosis	2.45e-06	0.000316	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ADCY5—osteoporosis	2.4e-06	0.00031	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GPX1—osteoporosis	2.39e-06	0.000308	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP19A1—osteoporosis	2.35e-06	0.000302	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—POMC—osteoporosis	2.34e-06	0.000302	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ENO1—osteoporosis	2.27e-06	0.000292	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ADCY5—osteoporosis	2.26e-06	0.000292	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—MTHFR—osteoporosis	2.26e-06	0.000292	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GPX1—osteoporosis	2.26e-06	0.000291	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PSMA2—osteoporosis	2.23e-06	0.000288	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PSMA5—osteoporosis	2.23e-06	0.000288	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—MTHFR—osteoporosis	2.21e-06	0.000285	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—MTHFR—osteoporosis	2.08e-06	0.000268	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL6—osteoporosis	2.08e-06	0.000268	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ADCY5—osteoporosis	1.92e-06	0.000247	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GPX1—osteoporosis	1.91e-06	0.000246	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.81e-06	0.000233	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—POMC—osteoporosis	1.81e-06	0.000233	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—POMC—osteoporosis	1.77e-06	0.000228	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—MTHFR—osteoporosis	1.76e-06	0.000227	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—POMC—osteoporosis	1.66e-06	0.000215	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ADCY5—osteoporosis	1.48e-06	0.000191	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GPX1—osteoporosis	1.47e-06	0.00019	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—POMC—osteoporosis	1.41e-06	0.000182	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—MTHFR—osteoporosis	1.36e-06	0.000175	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—POMC—osteoporosis	1.09e-06	0.00014	CbGpPWpGaD
